Brain & Spine Institute
Podcast: What if Your Surgeon Had X-Ray Vision?
Dr. Isaac Moss, who recently performed the first augmented reality spine surgery in central Connecticut, explains this high-tech "see-through" surgery.
Neurosurgeon Chief Dr. Ketan Bulsara Receives Lifetime Achievement Award
Dr. Ketan Bulsara, chief of neurosurgery at UConn Health, has received a lifetime achievement award from the Connecticut Association of Physicians of Indian Origin (CAPI).
UConn Health Minute: Complex Spine Disorders
A complex spine disorder is a serious condition that can be painful and limit your daily activities. Because it’s more difficult to treat, UConn Health has assembled a collaborative, multidisciplinary team who can expertly handle all aspects of your care.
Elite Expertise in Brain and Spine Disorders
Two physicians from the Brain and Spine Institute describe UConn Health's collaborative approach to treating those suffering from brain tumors, strokes, and other disorders of the brain and spine.
Stress Pushes Brain Cancer Cells to Adapt
Glioblastoma multiformes are aggressive brain tumors with evasive properties. UConn Health is collaborating with The Jackson Laboratory for Genomic Medicine to study them, and have published evidence that potentially could provide insight leading to more effective treatment.
Guidance to Treat Underdiagnosed Spine Problem Conceived at UConn Health
UConn surgeons and medical students establish a grading scale, named for Dr. Hilary Onyiuke, to help physicians manage Bertolotti syndrome, a frequently underrecognized debilitating spine condition.
Can Polio Virus Help Treat Brain Tumors?
UConn Health is enrolling patients in a national trial testing a therapy derived from the polio virus paired with an established cancer medication to treat a type of aggressive brain tumor
2021 Top Doctors Named by Connecticut Magazine
See which 43 UConn Health physicians have been named 2021 Top Doctors by Connecticut Magazine. Plus, read more about four UConn Health doctors and their additional unique talents beyond their daily practice of medicine.
High-Profile Brain Tumor Therapy Trial Chooses UConn Health
An immunotherapy derived from the polio virus has shown improved survival rates in early-phase trials in patients with an aggressive type of brain tumor known as glioblastoma. UConn Health will be one of a select few sites in the U.S. for the second phase, which will pair it with the cancer immunotherapy pembrolizumab (Keytruda).
The Brain and Spine Institute at UConn Health
UConn Health has brought together our world-renowned experts from neurology, neurosurgery, spine surgery, non-operative spine care, and radiology to offer comprehensive, personalized care at The Brain and Spine Institute at UConn Health.